Journal article
Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study.
- Abstract:
-
Aims Statins reduce LDL cholesterol (LDL-C) and the risk of vascular events, but it remains uncertain whether there is clinically relevant genetic variation in their efficacy. This study of 18 705 individuals aims to identify genetic variants related to the lipid response to simvastatin and assess their impact on vascular risk response.
Methods and results A genome-wide study of the LDL-C and apolipoprotein B (ApoB) response to 40 mg simvastatin dail...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 323.5KB)
-
- Publisher copy:
- 10.1093/eurheartj/ehs344
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
Medical Research Council
More from this funder
Merck
More from this funder
British Heart Foundation
More from this funder
Roche Vitamins Ltd
More from this funder
Bibliographic Details
- Publisher:
- Oxford University Press Publisher's website
- Journal:
- European heart journal Journal website
- Volume:
- 34
- Issue:
- 13
- Pages:
- 982-992
- Publication date:
- 2013-04-01
- DOI:
- EISSN:
-
1522-9645
- ISSN:
-
0195-668X
- Source identifiers:
-
358301
Item Description
- Language:
- English
- Keywords:
- UUID:
-
uuid:b7d20a03-6de4-4c70-9176-2b36c9aa6f66
- Local pid:
- pubs:358301
- Deposit date:
- 2013-11-16
Terms of use
- Copyright holder:
- Hopewell et al
- Copyright date:
- 2013
- Notes:
- Copyright © 2012 Hopewell et al. Published by Oxford University Press on behalf of European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
If you are the owner of this record, you can report an update to it here: Report update to this record